of migraine. more than 4 million of them have at least 15 migraine days each month. even though many drugs prevent and treat these headaches,
. august 2, 2017
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
august 2, 2017
.